Related Experiment Video
Updated: Aug 15, 2026

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Sleepiness in pregnancy and adverse perinatal outcomes
Rachel Friedlander1, Xiaoning Huang2, Phyllis Zee3
1Department of Obstetrics and Gynecology Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Background:
Sleep disorders in pregnancy have been associated with adverse pregnancy outcomes including hypertensive disorders of pregnancy, preterm birth, and gestational diabetes mellitus, yet these findings are largely from retrospective studies. Using data from a prospective study that used validated tools to assess sleepiness in pregnancy, we aimed to assess the association of sleepiness in pregnancy with adverse pregnancy outcomes.
Methods:
In this secondary analysis of data from a large, diverse prospective cohort of nulliparous individuals conducted at eight United States medical centers, those with self-reported sleep data were included. Sleepiness was evaluated in early (6-13 weeks) and mid-pregnancy (22-29 weeks) via the Epworth Sleepiness Scale, a validated tool to assess daytime sleep propensity (i.e., the ability to fall and stay asleep). Those with scores ≤10 were categorized as having no sleepiness (referent), 11-15 moderate sleepiness, and 16-24 severe sleepiness. The outcomes were hypertensive disorders of pregnancy, gestational diabetes, preterm birth, and small-for-gestational-age birth < 10 percentile. Multivariable logistic regression analysis adjusting for multiple potential confounders was performed to evaluate the associations of moderate and severe sleepiness with each outcome.
Results:
Of 6806 eligible participants who completed daytime sleepiness questionnaires at both time points, the mean score in early and mid-pregnancy was 7.8 (standard deviation 4.1) and 6.5 (standard deviation 4.0), respectively. In early pregnancy, 20.0% and 4.3% of people reported moderate and severe daytime sleepiness, respectively; in mid-pregnancy, 14.4% and 2.5% of people experienced moderate and severe sleepiness. Severe sleepiness in mid-pregnancy was associated with gestational diabetes (7.1% severe sleepiness vs. 3.8% no sleepiness; adjusted odds ratio [aOR], 1.78; 95% confidence interval [CI], 1.01-3.12) and small-for-gestational-age birth (14.8% severe sleepiness vs. 10.3% no sleepiness; aOR, 1.35; 95% CI, 1.06-1.71).
Conclusions:
Severe daytime sleepiness during mid-pregnancy, a symptom reflective of sleep quality, length, and often sleep disordered breathing, is associated with gestational diabetes and small-for-gestational-age birth, suggesting a potential relationship with maternal glucose metabolism and placental function.
Related Concept Videos
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Teratogenicity
Sleep Apnea
The condition is more prevalent among...
Management of Insomnia
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:

